Ian Frazer

Scientific Advisor at Khloris Biosciences

Professor Ian Frazer is a clinician-scientist, trained as a clinical immunologist in Scotland. As a professor at the University of Queensland, he leads a research group working at TRI in Brisbane, Australia on the immunobiology of epithelial cancers. He is recognized as co-inventor of the technology enabling the HPV vaccines, currently used worldwide to help prevent cervical cancer. He heads a biotechnology company, Jingang Medicine (Aus) Pty Ltd, working on new vaccine technologies, and is a board member of several companies and not-for-profit organizations. He was the inaugural president of the Australian Academy of Health and Medical Sciences and a member of the Australian National Science and Technology Council. He chairs the Australian Medical Research Advisory Board of the Medical Research Future Fund. He was recognized as Australian of the Year in 2006. He was the recipient of the Prime Ministers Prize for Science, and of the Balzan Prize, in 2008, and was elected Fellow of the Royal Society of London in 2012. He was appointed Companion of the Order of Australia in the Queen's Birthday Honours list in 2013.

Location

Brisbane, Australia

Links


Org chart

This person is not in the org chart


Teams


Offices

This person is not in any offices


Khloris Biosciences

Khloris Biosciences is a private biotechnology company located in the San Francisco Bay Area. They are dedicated to revolutionizing medical treatment and prevention of cancer and other diseases by harnessing the unlimited immunotherapeutic potential of induced pluripotent stem cells (iPSCs) for drug discovery, vaccine, and cell therapies.


Industries

Employees

1-10

Links